Function of the Parabrachial Nucleus to Central Amydala Pathway in Pain-Related Plasticity

臂旁核至中央杏仁核通路在疼痛相关可塑性中的功能

基本信息

项目摘要

PROJECT SUMMARY The annual national health cost for chronic pain conditions ranges between 560 to 635 billion dollars, which is higher than the combined costs for cancer, diabetes, and cardiovascular diseases. Chronic pain patients live with a lower quality of life that is further aggravated by patients’ frequent comorbidities with mental health disorders and substance abuse problems. Despite being a significant health concern, the biological mechanisms underlying chronic pain conditions have not been completely identified. Recently, the central amygdala (CeA) has been identified as an important center for pain modulation, with a dual function on pain perception through the activity of two separate cell populations: pain-promoting (pronociceptive) protein kinase c delta-expressing cells (CeA-PKCδ+) and antinociceptive somatostatin-expressing cells. The purpose of this research proposal is to further understand the circuit mechanisms underlying those findings by studying the synaptic connectivity changes behind CeA-PKCδ+ cells pronociceptive function. The central hypothesis of this proposal is that selective strengthening of nociceptive inputs to CeA-PKCδ+ neurons underlies behavioral hypersensitivity following injury. It is known that nociceptive information is conveyed to the CeA by projections sent from the lateral parabrachial nucleus (LPB), a pontine structure critical for pain-related information processing. Therefore, this proposal will test whether injury-related potentiation of the LPB to CeA pathway is specific to CeA-PKCδ+ neurons, whether this potentiation drives pain-related behavioral hypersensitivity, and whether this potentiation is necessary for injury-induced behavioral hypersensitivity. In Aim 1, the preliminary data showing injury-induced potentiation of excitatory synaptic transmission onto CeA-PKCδ+ neurons will be further investigated by dissecting the function of excitatory LPB inputs using ex vivo optogenetically-assisted circuit mapping. In Aim 2, the in vivo dynamics of the LPB to CeA pathway in freely behaving animals in terms of CeA-PKCδ+ neuronal activity and pain-related behavioral hypersensitivity will be established. Furthermore, the goal in Aim 3 is to establish a causal link between LPB to CeA pathway function, pain-related behaviors, and CeA-PKCδ+ cells neuronal activation. The experiments of Aim 1 will provide the trainee the opportunity to improve his current ex vivo electrophysiological skills. The experiments of Aims 2 and 3 will provide the trainee the opportunity to receive training in cutting-edge in vivo neurocircuitry tools to complete the experiments proposed and to address the biological questions in these aims. The findings obtained from the proposed research will expand our understanding of how the brain modulates pain, which might ultimately lead to the identification of better treatment options for individuals suffering from chronic pain conditions.
项目摘要 每年用于慢性疼痛的国家医疗费用在5600亿到6350亿美元之间, 这比癌症、糖尿病和心血管疾病的总成本还要高。慢性疼痛患者 生活质量较低,患者经常患有精神健康的共病, 精神障碍和药物滥用问题。尽管这是一个重大的健康问题, 潜在的慢性疼痛状况尚未完全确定。最近,中央杏仁核(CeA) 已被确定为疼痛调节的重要中心,通过以下方式对疼痛感知具有双重功能: 两个单独细胞群的活性:表达促痛(疼痛感受)蛋白激酶C δ 细胞(CeA-PKCδ+)和抗伤害感受性生长抑素表达细胞。本研究提案的目的是 通过研究突触连接,进一步了解这些发现背后的电路机制 CeA-PKCδ+细胞原伤害感受功能的改变。这一提议的核心假设是, 选择性加强CeA-PKCδ+神经元的伤害性传入是行为超敏反应的基础 受伤后。已知伤害性信息通过从小脑顶发出的投射传递到CeA。 外侧臂旁核(LPB),一个对疼痛相关信息处理至关重要的脑桥结构。因此,我们认为, 该提案将测试LPB对CeA通路的损伤相关增强作用是否对CeA-PKCδ+具有特异性 神经元,这种增强是否驱动疼痛相关的行为超敏反应,以及这种增强是否 是损伤诱导的行为超敏反应所必需的在目标1中,初步数据显示, 将进一步研究CeA-PKCδ+神经元上兴奋性突触传递的增强, 使用离体光遗传学辅助电路映射剖析兴奋性LPB输入的功能。在目标2中, 在自由行为动物中,LPB至CeA通路在CeA-PKCδ+神经元方面的体内动力学 将建立活动和疼痛相关的行为超敏反应。此外,目标3的目标是 建立LPB与CeA通路功能、疼痛相关行为和CeA-PKCδ+细胞之间的因果关系 神经元激活目标1的实验将为受训者提供机会,以提高他目前的经验。 活体电生理技能目标2和目标3的实验将为受训者提供机会, 尖端体内神经回路工具的培训,以完成拟议的实验,并解决 生物学问题在这些目标。从拟议的研究中获得的结果将扩大我们的 了解大脑如何调节疼痛,这可能最终导致更好的识别 为患有慢性疼痛病症的个体提供治疗选择。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.
  • DOI:
    10.3390/cells11203262
  • 发表时间:
    2022-10-17
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Soler-Cedeno, Omar;Xi, Zheng-Xiong
  • 通讯作者:
    Xi, Zheng-Xiong
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Omar Soler-Cedeno其他文献

Omar Soler-Cedeno的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Omar Soler-Cedeno', 18)}}的其他基金

Hippocampal Role in Extinction Induced Prefrontal Plasticity
海马在消退诱导的前额叶可塑性中的作用
  • 批准号:
    8837890
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了